| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymph Nodes | 24 | 2024 | 3466 | 4.080 |
Why?
|
| Graft Rejection | 43 | 2023 | 4504 | 4.080 |
Why?
|
| Graft Survival | 31 | 2024 | 3904 | 3.310 |
Why?
|
| Heart Transplantation | 27 | 2024 | 3299 | 2.990 |
Why?
|
| Serpins | 6 | 2020 | 245 | 2.120 |
Why?
|
| T-Lymphocytes, Regulatory | 20 | 2024 | 3113 | 1.910 |
Why?
|
| Rivers | 3 | 2021 | 65 | 1.850 |
Why?
|
| Islets of Langerhans Transplantation | 14 | 2024 | 747 | 1.850 |
Why?
|
| Kidney Transplantation | 21 | 2023 | 4278 | 1.610 |
Why?
|
| Dendritic Cells | 17 | 2019 | 2747 | 1.610 |
Why?
|
| Diabetes Mellitus, Type 1 | 19 | 2023 | 3446 | 1.460 |
Why?
|
| Thrombotic Microangiopathies | 3 | 2018 | 125 | 1.430 |
Why?
|
| Ecosystem | 3 | 2021 | 489 | 1.390 |
Why?
|
| Stromal Cells | 5 | 2022 | 1335 | 1.330 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 7 | 2020 | 504 | 1.300 |
Why?
|
| Reperfusion Injury | 4 | 2019 | 1043 | 1.280 |
Why?
|
| Mice, Inbred BALB C | 30 | 2024 | 6217 | 1.280 |
Why?
|
| Mesenchymal Stem Cells | 9 | 2020 | 1663 | 1.250 |
Why?
|
| Kidney | 15 | 2023 | 7071 | 1.230 |
Why?
|
| Skin Transplantation | 5 | 2019 | 1097 | 1.230 |
Why?
|
| Transplants | 2 | 2021 | 209 | 1.200 |
Why?
|
| Nanomedicine | 3 | 2023 | 289 | 1.200 |
Why?
|
| Organ Transplantation | 5 | 2023 | 1172 | 1.120 |
Why?
|
| Mice, Inbred C57BL | 49 | 2024 | 22337 | 1.120 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 2 | 2017 | 42 | 1.110 |
Why?
|
| Drug Delivery Systems | 6 | 2023 | 2210 | 1.050 |
Why?
|
| Nanoparticles | 8 | 2023 | 1966 | 1.050 |
Why?
|
| Membrane Proteins | 9 | 2024 | 7866 | 1.040 |
Why?
|
| Fibroblasts | 6 | 2024 | 4164 | 1.020 |
Why?
|
| Immunologic Factors | 5 | 2019 | 1594 | 1.000 |
Why?
|
| Mice | 80 | 2024 | 81863 | 0.990 |
Why?
|
| Interleukin-6 | 5 | 2019 | 3226 | 0.990 |
Why?
|
| Kidney Diseases | 7 | 2023 | 2101 | 0.990 |
Why?
|
| Transplantation Tolerance | 6 | 2021 | 641 | 0.980 |
Why?
|
| Animals | 107 | 2024 | 168887 | 0.960 |
Why?
|
| Tacrolimus | 3 | 2018 | 753 | 0.930 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 2020 | 1352 | 0.920 |
Why?
|
| Drug Carriers | 2 | 2018 | 702 | 0.890 |
Why?
|
| Granzymes | 5 | 2020 | 278 | 0.860 |
Why?
|
| Mice, Inbred NOD | 15 | 2023 | 1837 | 0.850 |
Why?
|
| Renin-Angiotensin System | 4 | 2010 | 735 | 0.840 |
Why?
|
| CD4-Positive T-Lymphocytes | 8 | 2021 | 4410 | 0.800 |
Why?
|
| Endothelium, Lymphatic | 2 | 2020 | 63 | 0.790 |
Why?
|
| Immunosuppressive Agents | 15 | 2023 | 4215 | 0.790 |
Why?
|
| CD40 Ligand | 2 | 2022 | 528 | 0.790 |
Why?
|
| Mice, Knockout | 27 | 2024 | 14466 | 0.760 |
Why?
|
| T-Lymphocytes | 20 | 2024 | 10263 | 0.750 |
Why?
|
| Fibrosis | 5 | 2024 | 2073 | 0.730 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 6 | 2022 | 5753 | 0.730 |
Why?
|
| Immunity | 4 | 2022 | 1002 | 0.700 |
Why?
|
| CD8-Positive T-Lymphocytes | 8 | 2024 | 4652 | 0.700 |
Why?
|
| Graft vs Host Disease | 6 | 2020 | 3079 | 0.700 |
Why?
|
| Receptors, Leptin | 1 | 2022 | 352 | 0.690 |
Why?
|
| Laminin | 4 | 2023 | 404 | 0.670 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2021 | 618 | 0.650 |
Why?
|
| Podocytes | 2 | 2024 | 402 | 0.640 |
Why?
|
| Receptors, Chemokine | 5 | 2007 | 652 | 0.640 |
Why?
|
| Chemokines | 6 | 2023 | 962 | 0.640 |
Why?
|
| Glomerulonephritis | 2 | 2018 | 333 | 0.640 |
Why?
|
| Transplantation, Homologous | 19 | 2018 | 4860 | 0.630 |
Why?
|
| Pancreas | 4 | 2023 | 1699 | 0.630 |
Why?
|
| Tissue Donors | 8 | 2021 | 2390 | 0.620 |
Why?
|
| Venules | 3 | 2024 | 161 | 0.610 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2017 | 2880 | 0.610 |
Why?
|
| Up-Regulation | 5 | 2024 | 4141 | 0.600 |
Why?
|
| Manipulation, Orthopedic | 2 | 2017 | 40 | 0.590 |
Why?
|
| Cold Ischemia | 1 | 2018 | 72 | 0.590 |
Why?
|
| Cell Movement | 8 | 2020 | 5197 | 0.560 |
Why?
|
| Kidney Glomerulus | 5 | 2014 | 571 | 0.560 |
Why?
|
| Receptors, CCR5 | 4 | 2010 | 491 | 0.560 |
Why?
|
| Bone Marrow Transplantation | 4 | 2016 | 2730 | 0.560 |
Why?
|
| Integrin beta3 | 2 | 2007 | 120 | 0.550 |
Why?
|
| Tenotomy | 1 | 2017 | 53 | 0.550 |
Why?
|
| Serine Endopeptidases | 2 | 2013 | 1027 | 0.540 |
Why?
|
| Inflammation | 13 | 2023 | 10860 | 0.540 |
Why?
|
| Disease Models, Animal | 18 | 2021 | 18322 | 0.530 |
Why?
|
| Casts, Surgical | 2 | 2017 | 184 | 0.530 |
Why?
|
| Acute Kidney Injury | 2 | 2019 | 1943 | 0.520 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 2 | 2018 | 696 | 0.520 |
Why?
|
| Orthotic Devices | 1 | 2017 | 131 | 0.520 |
Why?
|
| Lupus Nephritis | 3 | 2024 | 323 | 0.510 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2024 | 637 | 0.500 |
Why?
|
| OX40 Ligand | 1 | 2015 | 57 | 0.500 |
Why?
|
| Cytokines | 14 | 2023 | 7436 | 0.490 |
Why?
|
| Membrane Glycoproteins | 3 | 2021 | 3702 | 0.490 |
Why?
|
| Water Movements | 1 | 2015 | 17 | 0.490 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2018 | 373 | 0.480 |
Why?
|
| Diabetes Mellitus, Experimental | 4 | 2010 | 1121 | 0.480 |
Why?
|
| Hematologic Neoplasms | 2 | 2018 | 1926 | 0.470 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2018 | 482 | 0.460 |
Why?
|
| NF-kappa B | 5 | 2024 | 2495 | 0.460 |
Why?
|
| Quinoxalines | 2 | 2017 | 296 | 0.460 |
Why?
|
| Lymphocyte Activation | 7 | 2021 | 5502 | 0.450 |
Why?
|
| Angiotensin II | 3 | 2009 | 844 | 0.450 |
Why?
|
| Fluorocarbons | 1 | 2019 | 498 | 0.450 |
Why?
|
| Polymorphism, Genetic | 5 | 2012 | 4249 | 0.440 |
Why?
|
| Lymphotoxin beta Receptor | 3 | 2024 | 26 | 0.440 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 340 | 0.440 |
Why?
|
| Receptors, CCR2 | 4 | 2008 | 215 | 0.440 |
Why?
|
| Biocompatible Materials | 2 | 2019 | 1689 | 0.440 |
Why?
|
| Insulin-Secreting Cells | 3 | 2022 | 899 | 0.430 |
Why?
|
| Thiazolidinediones | 2 | 2017 | 460 | 0.420 |
Why?
|
| Iran | 6 | 2015 | 760 | 0.420 |
Why?
|
| Transplantation Conditioning | 2 | 2018 | 1635 | 0.420 |
Why?
|
| Polyesters | 2 | 2016 | 373 | 0.420 |
Why?
|
| Kidney Failure, Chronic | 2 | 2018 | 2505 | 0.410 |
Why?
|
| Clubfoot | 3 | 2020 | 87 | 0.410 |
Why?
|
| Lymphotoxin-alpha | 2 | 2024 | 94 | 0.390 |
Why?
|
| Chemokine CXCL12 | 3 | 2024 | 457 | 0.380 |
Why?
|
| Immunologic Memory | 2 | 2015 | 1377 | 0.370 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 1520 | 0.370 |
Why?
|
| Hydrogels | 3 | 2024 | 729 | 0.360 |
Why?
|
| Humans | 105 | 2024 | 766351 | 0.360 |
Why?
|
| Homozygote | 1 | 2015 | 1774 | 0.350 |
Why?
|
| Mineral Oil | 1 | 2010 | 21 | 0.350 |
Why?
|
| Macrophage Activation | 1 | 2013 | 553 | 0.350 |
Why?
|
| Students, Nursing | 1 | 2010 | 45 | 0.350 |
Why?
|
| Mentally Ill Persons | 1 | 2011 | 124 | 0.350 |
Why?
|
| Tissue and Organ Procurement | 1 | 2018 | 988 | 0.340 |
Why?
|
| Receptors, Nicotinic | 1 | 2013 | 494 | 0.340 |
Why?
|
| Los Angeles | 2 | 2021 | 244 | 0.340 |
Why?
|
| Community-Based Participatory Research | 1 | 2012 | 223 | 0.340 |
Why?
|
| Cerebral Arteries | 1 | 2012 | 490 | 0.330 |
Why?
|
| Object Attachment | 1 | 2012 | 327 | 0.330 |
Why?
|
| Neoplasms | 7 | 2022 | 22343 | 0.330 |
Why?
|
| Urban Health | 1 | 2012 | 532 | 0.330 |
Why?
|
| Flow Cytometry | 8 | 2021 | 5890 | 0.320 |
Why?
|
| Immune Tolerance | 5 | 2024 | 2324 | 0.320 |
Why?
|
| Child of Impaired Parents | 1 | 2012 | 462 | 0.310 |
Why?
|
| Mice, Transgenic | 10 | 2022 | 9539 | 0.310 |
Why?
|
| Homeostasis | 3 | 2022 | 3341 | 0.310 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 2628 | 0.300 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 1374 | 0.300 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2023 | 975 | 0.300 |
Why?
|
| Interferon-gamma | 5 | 2023 | 3159 | 0.300 |
Why?
|
| Hyperglycemia | 5 | 2022 | 1389 | 0.290 |
Why?
|
| Immunotherapy | 3 | 2023 | 4749 | 0.290 |
Why?
|
| Lymphatic Vessels | 3 | 2022 | 356 | 0.290 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2015 | 1802 | 0.290 |
Why?
|
| Parent-Child Relations | 1 | 2012 | 772 | 0.290 |
Why?
|
| Cyclosporine | 1 | 2010 | 778 | 0.290 |
Why?
|
| Selectins | 1 | 2007 | 101 | 0.290 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 1762 | 0.280 |
Why?
|
| Endothelial Cells | 4 | 2024 | 3576 | 0.280 |
Why?
|
| Gene Targeting | 1 | 2010 | 840 | 0.280 |
Why?
|
| Nursing Staff, Hospital | 1 | 2010 | 350 | 0.280 |
Why?
|
| Immune Evasion | 1 | 2010 | 376 | 0.280 |
Why?
|
| Killer Cells, Natural | 4 | 2011 | 2210 | 0.270 |
Why?
|
| Signal Transduction | 13 | 2024 | 23611 | 0.270 |
Why?
|
| Receptors, CXCR4 | 2 | 2010 | 729 | 0.270 |
Why?
|
| Th2 Cells | 5 | 2018 | 1078 | 0.260 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 588 | 0.260 |
Why?
|
| Ischemia | 2 | 2017 | 1904 | 0.260 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 3 | 2021 | 306 | 0.260 |
Why?
|
| Chemokines, CC | 1 | 2007 | 285 | 0.250 |
Why?
|
| Cell Differentiation | 6 | 2023 | 11648 | 0.250 |
Why?
|
| Needs Assessment | 1 | 2012 | 1140 | 0.250 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 1245 | 0.250 |
Why?
|
| Male | 51 | 2024 | 363931 | 0.250 |
Why?
|
| Receptors, Purinergic P2X7 | 2 | 2018 | 86 | 0.250 |
Why?
|
| Immunomodulation | 2 | 2019 | 548 | 0.250 |
Why?
|
| Oxidative Stress | 2 | 2014 | 3141 | 0.250 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 2 | 1999 | 335 | 0.240 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 1805 | 0.240 |
Why?
|
| Complement System Proteins | 2 | 2021 | 738 | 0.240 |
Why?
|
| Lumbosacral Region | 1 | 2006 | 294 | 0.240 |
Why?
|
| Islets of Langerhans | 4 | 2022 | 1350 | 0.240 |
Why?
|
| Microspheres | 2 | 2019 | 774 | 0.240 |
Why?
|
| Sacrum | 1 | 2006 | 273 | 0.230 |
Why?
|
| Interprofessional Relations | 1 | 2010 | 998 | 0.230 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2004 | 48 | 0.230 |
Why?
|
| Female | 47 | 2024 | 396307 | 0.230 |
Why?
|
| Antibodies, Monoclonal | 5 | 2017 | 9243 | 0.220 |
Why?
|
| Gene Expression Regulation | 7 | 2022 | 11919 | 0.220 |
Why?
|
| Silk | 1 | 2024 | 93 | 0.220 |
Why?
|
| Child Abuse | 1 | 2012 | 1090 | 0.220 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2020 | 347 | 0.220 |
Why?
|
| Nephrectomy | 2 | 2012 | 928 | 0.220 |
Why?
|
| Ultrasonography | 1 | 2017 | 5988 | 0.220 |
Why?
|
| Haplotypes | 1 | 2010 | 2727 | 0.220 |
Why?
|
| Sirolimus | 2 | 2022 | 1541 | 0.210 |
Why?
|
| Peptides | 2 | 2017 | 4344 | 0.210 |
Why?
|
| Bone Marrow Cells | 5 | 2015 | 2413 | 0.210 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 2230 | 0.210 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2019 | 2470 | 0.210 |
Why?
|
| ADAM Proteins | 1 | 2024 | 243 | 0.210 |
Why?
|
| Cell Proliferation | 7 | 2020 | 10438 | 0.210 |
Why?
|
| Urban Population | 1 | 2011 | 2038 | 0.210 |
Why?
|
| Antioxidants | 1 | 2010 | 1671 | 0.210 |
Why?
|
| Reticulin | 1 | 2022 | 19 | 0.200 |
Why?
|
| Interleukin-10 | 3 | 2018 | 1182 | 0.200 |
Why?
|
| Extracellular Matrix | 2 | 2022 | 1729 | 0.200 |
Why?
|
| Autoimmunity | 3 | 2021 | 1356 | 0.200 |
Why?
|
| Transendothelial and Transepithelial Migration | 2 | 2020 | 100 | 0.200 |
Why?
|
| Renal Dialysis | 1 | 2012 | 1790 | 0.200 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2017 | 904 | 0.190 |
Why?
|
| Macrophages | 4 | 2021 | 5782 | 0.190 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2022 | 50 | 0.190 |
Why?
|
| Time Factors | 15 | 2019 | 40112 | 0.190 |
Why?
|
| Tissue Adhesives | 2 | 2024 | 177 | 0.190 |
Why?
|
| Mental Disorders | 2 | 2012 | 6869 | 0.190 |
Why?
|
| Taurodeoxycholic Acid | 1 | 2021 | 13 | 0.190 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2021 | 128 | 0.190 |
Why?
|
| Cell Survival | 3 | 2017 | 5741 | 0.190 |
Why?
|
| Mice, Inbred DBA | 4 | 2021 | 624 | 0.190 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2024 | 2156 | 0.190 |
Why?
|
| Melanoma, Experimental | 1 | 2024 | 556 | 0.190 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 17082 | 0.180 |
Why?
|
| Spleen | 3 | 2018 | 2294 | 0.180 |
Why?
|
| Angiotensins | 1 | 2001 | 139 | 0.180 |
Why?
|
| Angioedema | 1 | 2002 | 184 | 0.180 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 5453 | 0.180 |
Why?
|
| STAT5 Transcription Factor | 1 | 2021 | 269 | 0.180 |
Why?
|
| Cell Line | 5 | 2022 | 15563 | 0.180 |
Why?
|
| Organoids | 2 | 2024 | 741 | 0.170 |
Why?
|
| Antigens, CD | 3 | 2018 | 4031 | 0.170 |
Why?
|
| Equinus Deformity | 1 | 2020 | 6 | 0.170 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2022 | 416 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 1602 | 0.170 |
Why?
|
| Fetal Macrosomia | 1 | 2020 | 138 | 0.170 |
Why?
|
| Ureteral Obstruction | 1 | 2021 | 293 | 0.170 |
Why?
|
| Valine | 1 | 2021 | 410 | 0.160 |
Why?
|
| Sarcoma, Kaposi | 1 | 2002 | 376 | 0.160 |
Why?
|
| HLA Antigens | 2 | 2015 | 1339 | 0.160 |
Why?
|
| Adult | 28 | 2022 | 223220 | 0.160 |
Why?
|
| Endothelium | 1 | 2022 | 768 | 0.160 |
Why?
|
| Blood Coagulation Disorders | 1 | 2022 | 350 | 0.160 |
Why?
|
| Platelet Count | 1 | 2021 | 784 | 0.160 |
Why?
|
| Methacrylates | 1 | 2019 | 109 | 0.160 |
Why?
|
| Talus | 1 | 2020 | 88 | 0.160 |
Why?
|
| Injections, Intraperitoneal | 3 | 2021 | 410 | 0.150 |
Why?
|
| Chemokine CCL21 | 3 | 2020 | 49 | 0.150 |
Why?
|
| Interleukin-4 | 4 | 2017 | 1155 | 0.150 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2002 | 329 | 0.150 |
Why?
|
| Cells, Cultured | 7 | 2022 | 18979 | 0.150 |
Why?
|
| Ankle Joint | 2 | 2020 | 452 | 0.150 |
Why?
|
| Integrin alpha Chains | 1 | 2018 | 93 | 0.150 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 995 | 0.150 |
Why?
|
| Coronavirus | 1 | 2020 | 155 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2021 | 3803 | 0.150 |
Why?
|
| Organ Preservation | 1 | 2021 | 400 | 0.150 |
Why?
|
| Integrin alpha2beta1 | 1 | 2017 | 17 | 0.150 |
Why?
|
| Oxides | 1 | 2019 | 402 | 0.150 |
Why?
|
| Isoantibodies | 2 | 2014 | 681 | 0.150 |
Why?
|
| Transplantation, Heterotopic | 1 | 2018 | 175 | 0.150 |
Why?
|
| Gene Deletion | 2 | 2020 | 2668 | 0.150 |
Why?
|
| Health Status | 1 | 2011 | 4085 | 0.140 |
Why?
|
| Ferric Compounds | 1 | 2019 | 376 | 0.140 |
Why?
|
| Megakaryocytes | 1 | 2021 | 557 | 0.140 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 245 | 0.140 |
Why?
|
| Renal Insufficiency | 1 | 2003 | 810 | 0.140 |
Why?
|
| Glioblastoma | 2 | 2023 | 3458 | 0.140 |
Why?
|
| Hormones | 1 | 2021 | 866 | 0.140 |
Why?
|
| New York City | 1 | 2020 | 736 | 0.140 |
Why?
|
| Gelatin | 1 | 2019 | 227 | 0.140 |
Why?
|
| Mycophenolic Acid | 1 | 2019 | 349 | 0.140 |
Why?
|
| Immunophenotyping | 2 | 2019 | 1866 | 0.140 |
Why?
|
| Transplantation Immunology | 2 | 2022 | 540 | 0.140 |
Why?
|
| Middle Aged | 24 | 2022 | 223092 | 0.140 |
Why?
|
| Herpesvirus 1, Human | 1 | 2023 | 743 | 0.140 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2010 | 661 | 0.140 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2002 | 566 | 0.140 |
Why?
|
| Lumbar Vertebrae | 1 | 2006 | 1878 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 3 | 2018 | 872 | 0.140 |
Why?
|
| Tumor Microenvironment | 2 | 2020 | 3943 | 0.140 |
Why?
|
| Mammals | 1 | 2022 | 1134 | 0.140 |
Why?
|
| Perfusion | 1 | 2021 | 1409 | 0.130 |
Why?
|
| Mucin-1 | 1 | 2021 | 536 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2010 | 3928 | 0.130 |
Why?
|
| Mental Health | 1 | 2011 | 3270 | 0.130 |
Why?
|
| Creatinine | 2 | 2019 | 1916 | 0.130 |
Why?
|
| Th17 Cells | 3 | 2018 | 788 | 0.130 |
Why?
|
| Braces | 1 | 2017 | 139 | 0.130 |
Why?
|
| Gastrectomy | 1 | 2021 | 693 | 0.130 |
Why?
|
| Virus Diseases | 1 | 2022 | 720 | 0.130 |
Why?
|
| Kidney Function Tests | 1 | 1998 | 684 | 0.130 |
Why?
|
| Reperfusion | 1 | 2017 | 268 | 0.130 |
Why?
|
| Replantation | 1 | 2017 | 145 | 0.130 |
Why?
|
| Amputation, Traumatic | 1 | 2017 | 135 | 0.130 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2015 | 26 | 0.130 |
Why?
|
| Skin Ulcer | 1 | 2017 | 131 | 0.130 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2002 | 1058 | 0.130 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 1511 | 0.130 |
Why?
|
| Receptors, CXCR3 | 2 | 2007 | 241 | 0.130 |
Why?
|
| Capillaries | 1 | 2018 | 750 | 0.120 |
Why?
|
| Receptors, Interleukin-2 | 2 | 2020 | 564 | 0.120 |
Why?
|
| Premedication | 1 | 2016 | 244 | 0.120 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2018 | 1441 | 0.120 |
Why?
|
| Epithelial Cells | 2 | 2024 | 3689 | 0.120 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 739 | 0.120 |
Why?
|
| Cancer Vaccines | 1 | 2023 | 1042 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 16040 | 0.120 |
Why?
|
| Immunoglobulins | 1 | 2018 | 853 | 0.120 |
Why?
|
| Polysaccharides | 1 | 2021 | 1020 | 0.120 |
Why?
|
| Contrast Media | 2 | 2019 | 5326 | 0.120 |
Why?
|
| Pharmaceutical Preparations | 1 | 2023 | 1083 | 0.120 |
Why?
|
| Mice, SCID | 4 | 2014 | 2626 | 0.120 |
Why?
|
| Fucose | 1 | 2015 | 115 | 0.120 |
Why?
|
| Histocompatibility Testing | 3 | 2007 | 726 | 0.120 |
Why?
|
| Fucosyltransferases | 1 | 2015 | 118 | 0.120 |
Why?
|
| Bartter Syndrome | 1 | 1994 | 23 | 0.120 |
Why?
|
| Biopsy | 4 | 2019 | 6778 | 0.120 |
Why?
|
| Adolescent | 10 | 2021 | 88877 | 0.120 |
Why?
|
| Skin Diseases | 1 | 2003 | 1083 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2022 | 2605 | 0.110 |
Why?
|
| Wound Healing | 2 | 2019 | 2797 | 0.110 |
Why?
|
| Fractures, Bone | 1 | 2006 | 2043 | 0.110 |
Why?
|
| Temperature | 1 | 2021 | 2229 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 2455 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2021 | 3788 | 0.110 |
Why?
|
| Oxygen | 2 | 2024 | 4251 | 0.110 |
Why?
|
| Multivariate Analysis | 4 | 2012 | 12060 | 0.110 |
Why?
|
| Metabolome | 1 | 2021 | 1009 | 0.110 |
Why?
|
| Antibodies | 2 | 2016 | 2421 | 0.110 |
Why?
|
| Complement Activation | 1 | 2016 | 447 | 0.110 |
Why?
|
| Swine | 3 | 2019 | 5981 | 0.110 |
Why?
|
| Young Adult | 8 | 2018 | 59906 | 0.110 |
Why?
|
| B-Lymphocytes | 3 | 2015 | 4784 | 0.110 |
Why?
|
| Congresses as Topic | 1 | 2018 | 811 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2022 | 4566 | 0.110 |
Why?
|
| Umbilical Cord | 1 | 2014 | 178 | 0.110 |
Why?
|
| Th1 Cells | 4 | 2012 | 1040 | 0.110 |
Why?
|
| Motion | 1 | 2017 | 782 | 0.110 |
Why?
|
| Biological Transport, Active | 1 | 2013 | 323 | 0.110 |
Why?
|
| Histocompatibility | 1 | 2014 | 327 | 0.110 |
Why?
|
| Apoptosis | 3 | 2020 | 9507 | 0.110 |
Why?
|
| Purinergic P2X Receptor Antagonists | 1 | 2012 | 24 | 0.100 |
Why?
|
| Endothelium, Vascular | 2 | 2016 | 4417 | 0.100 |
Why?
|
| Exosomes | 1 | 2017 | 417 | 0.100 |
Why?
|
| E-Selectin | 1 | 2015 | 575 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3109 | 0.100 |
Why?
|
| Treatment Outcome | 7 | 2018 | 65201 | 0.100 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2015 | 300 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3231 | 0.100 |
Why?
|
| Niacin | 1 | 2013 | 116 | 0.100 |
Why?
|
| ROC Curve | 2 | 2018 | 3616 | 0.100 |
Why?
|
| Disease-Free Survival | 2 | 2015 | 6845 | 0.100 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 222 | 0.100 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 2010 | 0.100 |
Why?
|
| Immediate-Early Proteins | 1 | 2015 | 444 | 0.100 |
Why?
|
| Ligands | 3 | 2019 | 3276 | 0.100 |
Why?
|
| History, 17th Century | 1 | 2012 | 108 | 0.100 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 11059 | 0.100 |
Why?
|
| Hypothermia, Induced | 1 | 2017 | 754 | 0.100 |
Why?
|
| Antigens, Surface | 1 | 2016 | 1617 | 0.100 |
Why?
|
| Health Surveys | 2 | 2012 | 4053 | 0.100 |
Why?
|
| History, Ancient | 1 | 2012 | 213 | 0.090 |
Why?
|
| Biosensing Techniques | 1 | 2017 | 640 | 0.090 |
Why?
|
| Extremities | 1 | 2017 | 869 | 0.090 |
Why?
|
| Fishes | 1 | 2015 | 607 | 0.090 |
Why?
|
| Microscopy, Confocal | 2 | 2017 | 1967 | 0.090 |
Why?
|
| Bariatric Surgery | 1 | 2021 | 996 | 0.090 |
Why?
|
| Paclitaxel | 1 | 2018 | 1727 | 0.090 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2017 | 1814 | 0.090 |
Why?
|
| Models, Animal | 1 | 2017 | 2119 | 0.090 |
Why?
|
| Antipyrine | 1 | 2010 | 40 | 0.090 |
Why?
|
| Iron | 1 | 2019 | 1812 | 0.090 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 1263 | 0.090 |
Why?
|
| Hematocrit | 1 | 2012 | 622 | 0.090 |
Why?
|
| Proteome | 1 | 2020 | 1893 | 0.090 |
Why?
|
| Preoperative Care | 1 | 2019 | 2253 | 0.090 |
Why?
|
| Age Factors | 4 | 2021 | 18395 | 0.090 |
Why?
|
| Autoantigens | 2 | 2014 | 886 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2013 | 598 | 0.090 |
Why?
|
| Infant | 5 | 2021 | 36458 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3605 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2013 | 642 | 0.090 |
Why?
|
| Stress, Mechanical | 1 | 2015 | 1672 | 0.080 |
Why?
|
| Lung Injury | 1 | 2014 | 432 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 10740 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2024 | 12147 | 0.080 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 213 | 0.080 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2011 | 266 | 0.080 |
Why?
|
| Apolipoproteins | 1 | 2012 | 327 | 0.080 |
Why?
|
| Aged | 12 | 2023 | 171208 | 0.080 |
Why?
|
| Lipopolysaccharides | 2 | 2017 | 2215 | 0.080 |
Why?
|
| Benzylamines | 1 | 2010 | 250 | 0.080 |
Why?
|
| Urea | 1 | 2012 | 449 | 0.080 |
Why?
|
| Heterocyclic Compounds | 1 | 2010 | 245 | 0.080 |
Why?
|
| Acute Disease | 3 | 2007 | 7239 | 0.080 |
Why?
|
| Child | 8 | 2021 | 80653 | 0.080 |
Why?
|
| History, 19th Century | 1 | 2012 | 713 | 0.080 |
Why?
|
| Stem Cells | 2 | 2014 | 3538 | 0.080 |
Why?
|
| NFATC Transcription Factors | 1 | 2011 | 392 | 0.080 |
Why?
|
| Isoantigens | 2 | 2012 | 562 | 0.080 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2010 | 174 | 0.080 |
Why?
|
| BK Virus | 1 | 2010 | 120 | 0.080 |
Why?
|
| Lymphoid Tissue | 1 | 2010 | 445 | 0.080 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2009 | 47 | 0.080 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 979 | 0.080 |
Why?
|
| Nephritis, Interstitial | 1 | 2010 | 157 | 0.080 |
Why?
|
| Interleukin-17 | 1 | 2015 | 923 | 0.080 |
Why?
|
| Postoperative Period | 3 | 2003 | 1824 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 2430 | 0.080 |
Why?
|
| Desensitization, Immunologic | 1 | 2014 | 546 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 1897 | 0.080 |
Why?
|
| Vascular Resistance | 1 | 2012 | 939 | 0.080 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 2015 | 511 | 0.080 |
Why?
|
| Oxidative Phosphorylation | 2 | 2024 | 502 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 5794 | 0.080 |
Why?
|
| Interleukins | 1 | 2013 | 794 | 0.080 |
Why?
|
| Disease Progression | 3 | 2020 | 13623 | 0.080 |
Why?
|
| HLA-D Antigens | 1 | 2008 | 130 | 0.080 |
Why?
|
| Primary Graft Dysfunction | 1 | 2009 | 112 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 1026 | 0.070 |
Why?
|
| Fluoroquinolones | 1 | 2010 | 307 | 0.070 |
Why?
|
| Immunity, Innate | 2 | 2023 | 3078 | 0.070 |
Why?
|
| Polyomavirus Infections | 1 | 2010 | 193 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2015 | 2930 | 0.070 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 2010 | 0.070 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2009 | 324 | 0.070 |
Why?
|
| Risk Factors | 5 | 2018 | 74825 | 0.070 |
Why?
|
| Lipoproteins, HDL | 1 | 2012 | 676 | 0.070 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2007 | 61 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2825 | 0.070 |
Why?
|
| Diabetic Nephropathies | 1 | 2014 | 975 | 0.070 |
Why?
|
| Protein Binding | 2 | 2019 | 9315 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2002 | 4049 | 0.070 |
Why?
|
| Postoperative Complications | 3 | 2007 | 15818 | 0.070 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 39269 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2019 | 2570 | 0.070 |
Why?
|
| Integrin alpha4beta1 | 1 | 2007 | 119 | 0.070 |
Why?
|
| Mitochondria | 2 | 2022 | 3676 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2017 | 2694 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2021 | 6422 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2003 | 4282 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 2002 | 0.070 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2007 | 153 | 0.070 |
Why?
|
| Coculture Techniques | 1 | 2010 | 1336 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2015 | 22243 | 0.060 |
Why?
|
| Hemoglobins | 1 | 2012 | 1531 | 0.060 |
Why?
|
| Cell Separation | 1 | 2011 | 1718 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2011 | 2272 | 0.060 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 5883 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 3424 | 0.060 |
Why?
|
| Stem Cell Transplantation | 1 | 2014 | 1600 | 0.060 |
Why?
|
| Child, Preschool | 5 | 2021 | 42568 | 0.060 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2007 | 381 | 0.060 |
Why?
|
| Focus Groups | 1 | 2012 | 1459 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2018 | 10092 | 0.060 |
Why?
|
| Reference Values | 2 | 2006 | 4912 | 0.060 |
Why?
|
| Lymphotoxin alpha1, beta2 Heterotrimer | 1 | 2024 | 4 | 0.060 |
Why?
|
| Aging | 3 | 2023 | 8724 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9521 | 0.060 |
Why?
|
| Prevalence | 2 | 2012 | 15820 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 12236 | 0.060 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2024 | 159 | 0.060 |
Why?
|
| Recurrence | 1 | 2017 | 8478 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2012 | 2740 | 0.060 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2004 | 58 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2020 | 81577 | 0.060 |
Why?
|
| Incidence | 2 | 2018 | 21506 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2012 | 2764 | 0.060 |
Why?
|
| Hypertension, Renal | 1 | 2004 | 135 | 0.060 |
Why?
|
| Pandemics | 2 | 2020 | 8728 | 0.050 |
Why?
|
| L-Selectin | 1 | 2004 | 212 | 0.050 |
Why?
|
| Cell Division | 2 | 2010 | 4474 | 0.050 |
Why?
|
| Mutation | 2 | 2018 | 30217 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 2062 | 0.050 |
Why?
|
| C-Peptide | 2 | 2020 | 443 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2024 | 11501 | 0.050 |
Why?
|
| Genotype | 3 | 2012 | 13032 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2002 | 5860 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2007 | 1525 | 0.050 |
Why?
|
| Focal Adhesions | 1 | 2023 | 113 | 0.050 |
Why?
|
| Immunoconjugates | 1 | 2010 | 976 | 0.050 |
Why?
|
| Kidney Tubules | 1 | 2024 | 453 | 0.050 |
Why?
|
| Prediabetic State | 1 | 2008 | 547 | 0.050 |
Why?
|
| Transplantation, Isogeneic | 1 | 2002 | 250 | 0.050 |
Why?
|
| Proinsulin | 1 | 2022 | 135 | 0.050 |
Why?
|
| Adoptive Transfer | 2 | 2019 | 828 | 0.050 |
Why?
|
| Melanoma | 1 | 2020 | 5699 | 0.050 |
Why?
|
| Rats, Nude | 1 | 2021 | 105 | 0.050 |
Why?
|
| Registries | 1 | 2018 | 8344 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 4348 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 1150 | 0.050 |
Why?
|
| Sialyltransferases | 1 | 2021 | 83 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2007 | 798 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2010 | 26279 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2022 | 183 | 0.050 |
Why?
|
| Engineering | 1 | 2021 | 56 | 0.050 |
Why?
|
| Infant, Newborn | 3 | 2020 | 26387 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2012 | 4187 | 0.050 |
Why?
|
| Hypertension | 1 | 2001 | 8614 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 1612 | 0.050 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2021 | 139 | 0.050 |
Why?
|
| Survival Rate | 1 | 2015 | 12825 | 0.050 |
Why?
|
| Cytochromes c | 1 | 2021 | 173 | 0.050 |
Why?
|
| Injections | 1 | 2024 | 839 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2021 | 74 | 0.050 |
Why?
|
| Cardiotonic Agents | 1 | 2024 | 540 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1889 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15897 | 0.050 |
Why?
|
| Germinal Center | 1 | 2023 | 379 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2012 | 8300 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1615 | 0.040 |
Why?
|
| Pharyngitis | 1 | 2002 | 221 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 9101 | 0.040 |
Why?
|
| Losartan | 1 | 2002 | 263 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2024 | 624 | 0.040 |
Why?
|
| Autoimmune Diseases | 2 | 2003 | 2249 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2021 | 610 | 0.040 |
Why?
|
| Enalapril | 1 | 2002 | 317 | 0.040 |
Why?
|
| Integrin alpha6 | 1 | 2020 | 30 | 0.040 |
Why?
|
| Probability | 1 | 2006 | 2475 | 0.040 |
Why?
|
| Dystroglycans | 1 | 2020 | 62 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2021 | 417 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2011 | 2594 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2007 | 3093 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 18075 | 0.040 |
Why?
|
| Chemokine CCL19 | 1 | 2019 | 37 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2023 | 608 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2021 | 873 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 41698 | 0.040 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1999 | 41 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 6507 | 0.040 |
Why?
|
| Bioreactors | 1 | 2020 | 244 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2004 | 1966 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 1055 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2022 | 1646 | 0.040 |
Why?
|
| Immunization | 1 | 2023 | 1218 | 0.040 |
Why?
|
| Italy | 1 | 2020 | 852 | 0.040 |
Why?
|
| Cough | 1 | 2002 | 599 | 0.040 |
Why?
|
| Basement Membrane | 1 | 1999 | 348 | 0.040 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 1999 | 86 | 0.040 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 153 | 0.040 |
Why?
|
| Psychotic Disorders | 1 | 2013 | 3275 | 0.040 |
Why?
|
| Vinculin | 1 | 2017 | 58 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2010 | 3068 | 0.040 |
Why?
|
| Cell Communication | 1 | 2024 | 1658 | 0.040 |
Why?
|
| Anxiety | 1 | 2012 | 4669 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2019 | 939 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6212 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2020 | 692 | 0.040 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2017 | 120 | 0.040 |
Why?
|
| Mannose-Binding Lectins | 1 | 2017 | 100 | 0.030 |
Why?
|
| Actins | 1 | 2024 | 2060 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 7840 | 0.030 |
Why?
|
| Compressive Strength | 1 | 2017 | 159 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2024 | 2900 | 0.030 |
Why?
|
| Rats | 2 | 2024 | 23718 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2021 | 1838 | 0.030 |
Why?
|
| RNA | 1 | 2006 | 2715 | 0.030 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 484 | 0.030 |
Why?
|
| Joint Capsule | 1 | 2016 | 68 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13639 | 0.030 |
Why?
|
| Proteomics | 2 | 2020 | 3906 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2017 | 730 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2024 | 1674 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 2014 | 2551 | 0.030 |
Why?
|
| Cadherins | 1 | 2020 | 901 | 0.030 |
Why?
|
| Mass Screening | 1 | 2011 | 5451 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2023 | 2115 | 0.030 |
Why?
|
| Tendon Transfer | 1 | 2016 | 125 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2015 | 201 | 0.030 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2015 | 140 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 733 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2015 | 915 | 0.030 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2015 | 176 | 0.030 |
Why?
|
| Dermis | 1 | 2015 | 203 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2017 | 637 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 592 | 0.030 |
Why?
|
| Estradiol | 1 | 2021 | 1947 | 0.030 |
Why?
|
| Indomethacin | 1 | 1994 | 323 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 1997 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2038 | 0.030 |
Why?
|
| Plasmapheresis | 1 | 2014 | 205 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1105 | 0.030 |
Why?
|
| Achilles Tendon | 1 | 2016 | 181 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 21157 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2020 | 1894 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2014 | 482 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2020 | 1490 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2002 | 2029 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1790 | 0.030 |
Why?
|
| Depression | 1 | 2012 | 8228 | 0.030 |
Why?
|
| Antibodies, Blocking | 1 | 2013 | 250 | 0.030 |
Why?
|
| Hyperoxia | 1 | 2014 | 259 | 0.030 |
Why?
|
| Immunocompetence | 1 | 2012 | 138 | 0.030 |
Why?
|
| Proteins | 1 | 2007 | 6002 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 12803 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2017 | 1179 | 0.020 |
Why?
|
| HLA-DR4 Antigen | 1 | 2011 | 22 | 0.020 |
Why?
|
| Insulin Resistance | 2 | 2021 | 3989 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 2013 | 479 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2020 | 1418 | 0.020 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2014 | 329 | 0.020 |
Why?
|
| Genes, MHC Class II | 1 | 2011 | 433 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14643 | 0.020 |
Why?
|
| United States | 1 | 2018 | 72909 | 0.020 |
Why?
|
| Phenotype | 1 | 2008 | 16718 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 1750 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 1883 | 0.020 |
Why?
|
| DNA | 1 | 2023 | 7205 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2014 | 667 | 0.020 |
Why?
|
| Living Donors | 1 | 2014 | 647 | 0.020 |
Why?
|
| Computational Biology | 1 | 2021 | 3564 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2010 | 227 | 0.020 |
Why?
|
| Boston | 2 | 2014 | 9333 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 3681 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 1331 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2014 | 2127 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2015 | 1560 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 2675 | 0.020 |
Why?
|
| Radiography | 1 | 2020 | 6967 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4888 | 0.020 |
Why?
|
| Antilymphocyte Serum | 1 | 2010 | 492 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2010 | 676 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 2815 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2007 | 102 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 2533 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2018 | 2977 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2007 | 214 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 2143 | 0.020 |
Why?
|
| Viremia | 1 | 2010 | 727 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 891 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2014 | 873 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2001 | 8532 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2014 | 2573 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2011 | 1851 | 0.010 |
Why?
|
| Monocytes | 1 | 2014 | 2599 | 0.010 |
Why?
|
| Gene Expression | 1 | 2017 | 7583 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 11217 | 0.010 |
Why?
|
| Sex Factors | 1 | 1998 | 10614 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9401 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6508 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 3439 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 2391 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 20706 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 17605 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 8536 | 0.010 |
Why?
|
| Survivors | 1 | 2012 | 2379 | 0.010 |
Why?
|
| Prognosis | 1 | 2002 | 29921 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1998 | 8925 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2002 | 24272 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2008 | 1625 | 0.010 |
Why?
|
| Viral Load | 1 | 2010 | 3385 | 0.010 |
Why?
|
| Insulin | 2 | 2007 | 6608 | 0.010 |
Why?
|
| Hospitalization | 1 | 2020 | 10812 | 0.010 |
Why?
|
| Glucagon | 1 | 2002 | 534 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2002 | 1767 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 30229 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 8041 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 2413 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 3407 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2012 | 9352 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 2513 | 0.010 |
Why?
|
| HIV Infections | 1 | 2003 | 17534 | 0.010 |
Why?
|
| Lung | 1 | 2014 | 10064 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 59527 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 20128 | 0.010 |
Why?
|
| Cadaver | 1 | 1999 | 1362 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 54809 | 0.010 |
Why?
|